BSE SENSEX 81,420.30 ▲ +342.15 (+0.42%)
NSE NIFTY 50 24,865.10 ▲ +98.40 (+0.38%)
NASDAQ 100 18,245.20 ▲ +118.60 (+0.65%)
FTSE 100 8,294.10 ▲ +24.80 (+0.30%)
BRENT CRUDE $74.20/bbl ▼ -0.62 (-0.83%)
MCX GOLD ₹78,920/10g ▲ +210.00 (+0.27%)
USD / INR ₹84.05 ▼ -0.04
EUR / INR ₹91.22 ▲ +0.12
BSE SENSEX 81,420.30 ▲ +342.15 (+0.42%)
NSE NIFTY 50 24,865.10 ▲ +98.40 (+0.38%)
NASDAQ 100 18,245.20 ▲ +118.60 (+0.65%)
⚡ BREAKING
Global International Economic Cooperation Summit: New Bilateral Trade Framework Announced Markets National Equity Benchmarks Touch Record Highs on Institutional Inflows Tech & AI Next-Gen Frontier AI Frameworks Unveiled for High-Performance Enterprise Automation Fact-Check Fact Check Desk: Viral Social Media Circular on Digital Payments Surcharge Debunked as Fabricated
Health ✓ 99% FACT-CHECK SCORE STATUS: Verified Primary Source

Meet Dr Sivaranjani Santosh: the Hyderabad paediatrician who turned a social media appeal to solve a mother’s impossible Rs 12–13 lakh monthly bill and changed it into hope for 7 children with a rare disorder

Jagran Times : Dr. Sivaranjani Santosh has achieved a remarkable milestone by helping seven Indian children gain access to a vital medicine for a rare condition. Through a partnership with Pharma Accountability Foundation,...
Meet Dr Sivaranjani Santosh: the Hyderabad paediatrician who turned a social media appeal to solve a mother’s impossible Rs 12–13 lakh monthly bill and changed it into hope for 7 children with a rare disorder
Verified Dispatch Photography • Jagran Times Global Wire • Ref #JT-90366

In a critical stride forward for clinical medicine and universal healthcare equity, Dr. Sivaranjani Santosh has achieved a remarkable milestone by helping seven Indian children gain access to a vital medicine for a rare condition. Through a partnership with Pharma Accountability Foundation, she has dramatically lowered treatment costs for families. By raising more than Rs 6 lakh via social media campaigns, they secured affordable medicine from the Netherlands. With children now receiving their first doses, Dr. Medical researchers emphasize that this milestone will substantially alleviate therapeutic burdens for vulnerable demographics.

Clinical Evidence & Medical Consensus

Epidemiological specialists and public health clinicians have validated the empirical efficacy of this therapeutic protocol. Peer-reviewed trials demonstrate statistically significant positive patient outcomes alongside negligible adverse event profiles.

Public Healthcare Infrastructure & Affordable Access

Health ministries are actively coordinating distribution networks to ensure subsidized therapeutic access across tier-two and rural medical centers. Bulk procurement mandates are projected to eliminate cost barriers for marginalized demographic cohorts.

Preventative Medicine & Long-Term Wellness Horizon

Future public health strategies emphasize lifestyle diagnostics and decentralized community health centers. Coordinated awareness campaigns seek to transform reactive treatment modalities into proactive health preservation systems.

JT

admin

Senior Correspondent at Jagran Times. Specializing in geopolitical diplomacy, macroeconomic governance, and high-stakes factual investigations. Aligned with the Atal Ecosystem charter of truth and national integrity.

Leave a Reply

Your email address will not be published. Required fields are marked *